We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 28.56%
2 Industrials 11.54%
3 Communication Services 11.47%
4 Financials 11.2%
5 Technology 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DKNG icon
101
DraftKings
DKNG
$11.9B
$18.8M 0.09%
+390,000
New +$20.7M
IPAXU
102
DELISTED
Inflection Point Acquisition Corp. Units
IPAXU
$18.8M 0.09%
+1,900,000
New +$18.8M
FIVN icon
103
FIVE9
FIVN
$2.54B
$18.5M 0.09%
+116,000
New +$21.2M
RC
104
Ready Capital
RC
$308M
$18M 0.08%
1,250,226
PNT
105
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$17.6M 0.08%
2,290,000
-110,000
-5% -$1M
NVAX icon
106
Novavax
NVAX
$1.31B
$17.4M 0.08%
83,713
+43,713
+109% +$9.63M
FVIV
107
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
$17M 0.08%
1,750,000
SEPA
108
DELISTED
SEP Acquisition Corp Class A Common Stock
SEPA
$16.9M 0.08%
+1,732,500
New +$17M
SHQA
109
DELISTED
Shelter Acquisition Corporation I Class A Common Stock
SHQA
$16M 0.07%
+1,650,000
New +$16M
BSKY
110
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
$15.2M 0.07%
+1,550,000
New +$15.1M
SRPT icon
111
Sarepta Therapeutics
SRPT
$1.77B
$15M 0.07%
+162,000
New +$12.5M
KYNB
112
Kyntra Bio
KYNB
$29.4M
$14.8M 0.07%
57,848
+291
+0.5% +$103K
KAHC
113
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$14.6M 0.07%
1,500,000
ASZ
114
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$14.6M 0.07%
1,500,000
ZEAL
115
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$14.3M 0.07%
510,000
RCEL icon
116
Avita Medical
RCEL
$240M
$14.2M 0.07%
800,000
DISA
117
DELISTED
Disruptive Acquisition Corporation I Class A Ordinary Shares
DISA
$13.6M 0.06%
1,400,000
AJRD
118
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$12.8M 0.06%
293,000
-252,000
-46% -$11.2M
YMM icon
119
Full Truck Alliance
YMM
$9.99B
$12.5M 0.06%
815,000
+54,251
+7% +$798K
FRXB
120
DELISTED
Forest Road Acquisition Corp. II
FRXB
$12.2M 0.06%
1,250,000
AGGR
121
DELISTED
Agile Growth Corp
AGGR
$11.7M 0.05%
1,200,000
GRND icon
122
Grindr
GRND
$2.95B
$10.9M 0.05%
1,080,000
SOND
123
DELISTED
Sonder
SOND
$10.9M 0.05%
55,000
PRDS
124
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$9.95M 0.05%
1,000,000
CAS
125
DELISTED
Cascade Acquisition Corp.
CAS
$9.85M 0.05%
990,000

Similar funds

Farallon Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Farallon Capital Management held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Farallon Capital Management withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Farallon Capital Management opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Farallon Capital Management's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Farallon Capital Management added most to Aramark in Q3 2021, an estimated $209M increase.
  • Farallon Capital Management's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Farallon Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Farallon Capital Management's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Farallon Capital Management opened 40 new positions and closed 34 in Q3 2021.
  • Farallon Capital Management's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.